Tempramed launches Vivi Cap Smart

Mr. Ron Nagar reports TEMPRAMED LAUNCHES NEW PRODUCT, VIVI CAP SMART, EXPANDING ITS PORTFOLIO TO INCLUDE A DIGITAL HEALTH OFFERING Tempramed Technologies Ltd. has launched a new product, Vivi Cap Smart, an advanced evolution of its flagship Vivi Cap product. The new device expands Tempramed's product portfolio by integrating digital health functionality with its established passive temperature protection technology. Vivi Cap Smart builds on the success of the original Vivi Cap, which provides continuous protection for insulin and GLP-1 pens against temperature fluctuations without the need for user intervention or maintenance. Insulin, and GLP-1 if exposed to temperatures outside of room temperature, can weaken or damage causing suboptimal treatment. Using its proprietary, space-grade technology, Tempramed's product portfolio protects and prevents insulin and other life-saving medication from being compromised, which reduces wasted medication, as well as negative patient outcomes. Vivi Cap Smart adds an integrated digital layer designed to support daily medication management by enabling users to track injection timing automatically and maintain an accurate log of insulin usage through an optional connected mobile application. This important data can be stored, tracked and shared with health care providers to ensure an integrated treatment plan. The introduction of Vivi Cap Smart represents a strategic step in Tempramed's transition toward a broader, whole-patient platform that combines physical device innovation with digital tools aimed at simplifying daily care for individuals managing chronic illnesses. Vivi Cap Smart is designed to complement Tempramed's existing product family by adding digital functionality that supports adherence, tracking and communication with caregivers and health care professionals. Key capabilities include: Temperature protection: maintains medication integrity using proprietary, patented technology: 24-seven, fully passive, low maintenance, power-free; Injection timing display: clearly shows the elapsed time since the last injection directly on the device; Digital logbook: records injection times and user-entered dose information through optional, mobile connected application; Data sharing: enables export of information to support collaboration with caregivers health care providers and corporates in connected health and artificial intelligence model. "Living with a chronic condition requires constant attention and decision making," said Ron Nagar, chief executive officer of Tempramed. "We are excited to launch the commercial availability of Vivi Cap Smart, the next-generation, digitally connected version of our core Vivi Cap product. With Vivi Cap Smart, we are extending our proprietary technology to address not only medication protection, but also the everyday challenges of remembering and managing important injections. This reflects our broader strategy to deliver practical, user-centred solutions that ease the burden of long-term care. Looking forward, we will continue to add to our product portfolio using our core technology to better serve patients globally." About Tempramed Technologies Ltd. Tempramed is a global leader in innovative, temperature-controlled medication storage solutions. Founded with the mission to safeguard the effectiveness of life-saving medications, Tempramed develops patented, Food and Drug Administration-registered, space-grade thermal insulation devices that work 24-seven without batteries or external power. With a proven product line including Vivi Cap and Vivi Epi, and a smart technology platform on the horizon, Tempramed enables patients and health care providers to confidently manage temperature-sensitive medications anywhere, any time. Headquartered in Israel with operations in North America, Europe and Asia, Tempramed is advancing the future of medication protection and adherence. We seek Safe Harbor.